TRVI vs TYRA Stock Comparison
TRVI currently leads TYRA in this stock comparison, with AIQ scores of 63 vs 49. The clearest difference is momentum.
What is the main difference between TRVI and TYRA?
TRVI leads the current stock comparison as Trevi Therapeutics, Inc., with the clearest separation coming from momentum and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Trevi Therapeutics, Inc. vs Tyra Biosciences, Inc.
TRVI leads
TRVI leads by 14 AIQ points, primarily on Momentum and Quality, but the lead has narrowed from 18 points over 30 sessions.
Competitive: 3 of 4 evidence groups support TRVI, its lead is narrowing, and its current signal state is conflicted.
Trevi Therapeutics, Inc.
Tyra Biosciences, Inc.
The Algovestiq AIQ Score currently favors TRVI over TYRA, 63 versus 49 as of Nov 15, 2026. TRVI's advantage is driven primarily by stronger momentum and quality. TRVI also shows the stronger technical structure relative to its 50-day moving average. 3 of 4 covered evidence groups favor TRVI today, and the comparison is rated Competitive on stability: the leader's advantage has been narrowing. TRVI lead: Weakening — the AIQ differential moved from 18 to 14 points over 30 sessions.
Compare Trevi Therapeutics, Inc. and Tyra Biosciences, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price return from daily closes; distributions are not included.
Price return comparison
Growth of $10,000, price only
Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.
Compare TRVI and TYRA against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Momentum52 vs 27TRVI +25
- Quality82 vs 75TRVI +7
- Risk Resilience51 vs 45TRVI +6
3 of 4 evidence groups favor TRVI. TRVI’s edge is concentrated in momentum and quality.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
Largest factor move: Momentum +6
New signals
- Low Volume Rally Warning — bearish, volume, short horizon (0.68x)
- TRIX Bullish Signal — bullish, momentum, short horizon
Largest factor move: Momentum -3
New signals
- Low Volume Rally Warning — bearish, volume, short horizon (0.60x)
- MACD Bearish Crossover — bearish, momentum, short horizon
- MACD Histogram Expanding Bearish — bearish, momentum, short horizon
TRVI's lead widened by 4 AIQ points in the latest session.
Deeper signal detail for each name lives on its own signals page — TRVI and TYRA both carry a full feed there.
The central trade-off
TRVI (Trevi Therapeutics, Inc.): the stronger current systematic profile, led by momentum and quality.
TYRA (Tyra Biosciences, Inc.): the counter-case, on fundamentals.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
TRVITRVI on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
TYRATYRA on combined revenue and EPS growth.
Value
EvenThe two are level on Value.
Momentum
TRVITRVI on the Momentum factor, by 25 points.
Lower downside
TRVITRVI on Risk Resilience, by 6 points.
Analyst upside
EvenAnalyst targets are level or not covered for both names.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | TRVI | TYRA | Note |
|---|---|---|---|
| Implied upside to target | — | +118.5% | Level |
| Target dispersion | — | +61.7% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 11 | 15 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
3 of 4 covered evidence groups favor TRVI. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | TRVI | 63 vs 49 |
| Fundamentals | TYRA | revenue growth 0% vs 0%; EPS growth -18.2% vs -7.2%; TTM ROE -7.1% vs -7.4%; gross margin 0% vs 0%; operating margin 0% vs 0% |
| Valuation | Not covered | Not covered |
| Technicals | TRVI | Price vs 50-day -2.7% vs -7.9%; vs 200-day -6% vs -31.9% |
| Risk Resilience | TRVI | Risk Resilience 51 vs 45 |
| Analyst expectations | Not covered | Not covered |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of TRVI and TYRA and are excluded from the count.
AIQ Decision Stability
The two are close enough that your objective, not the score, should decide.
- The AIQ gap is wide at 14 points. (supports the conclusion holding)
- The leader's advantage has been narrowing. (argues the conclusion is provisional)
- The lead has been steady session to session. (supports the conclusion holding)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on TRVI.
How the comparison changed
120 daily snapshots · May 27 – Nov 13TRVI lead: Weakening — the AIQ differential moved from 18 to 14 points over 30 sessions.
- Today
- TRVI +14
- 63 vs 49
- 7 sessions ago
- TRVI +17
- 62 vs 45
- 30 sessions ago
- TRVI +18
- 58 vs 40
- 90 sessions ago
- TRVI +29
- 79 vs 50
The lead has not changed hands in this window.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
2 bullish / 4 bearish / 2 neutral, conflicted
Only TRVI
- Beta Spike Warning — bearish, risk_regime, long horizon
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- TRIX Bullish Signal — bullish, momentum, short horizon
0 bullish / 5 bearish / 2 neutral
Only TYRA
- MACD Bearish Crossover — bearish, momentum, short horizon
- MACD Histogram Expanding Bearish — bearish, momentum, short horizon
Both carry 5 more signals that do not separate them: Death Cross Active, ADX Trend Weakening, ATR Expansion - Breakout Mode, Downtrend Structure Active, Low Volume Rally Warning.
TRVI leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price and the AIQ Score both moved up over the latest session (price +0.22%, AIQ +3 points).
Price is up while the AIQ Score moved down 1 points over the same session — price and model disagree (price +1.32%, AIQ -1 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1TYRA closes the Momentum gap — currently 25 points behind, the largest single contributor to TRVI's edge.
- 2TYRA's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3TRVI's conflicting signal state resolves bearish — it currently carries 2 bullish and 4 bearish rules at once.
- 4The narrowing continues — the lead has already given back 4 points over 30 sessions, and a further 14-point move would eliminate TRVI's advantage entirely.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
TYRA leads on balance| Metric | TRVI | TYRA |
|---|---|---|
| Revenue growth (YoY) | 0% | 0% |
| EPS growth (YoY) | -18.2% | -7.2% |
| Gross margin | 0% | 0% |
| Operating margin | 0% | 0% |
| Return on equity (TTM) | -7.1% | -7.4% |
| Debt to equity | 0 | 0.01 |
Performance
TRVI leads 4 of 6 windows| Metric | TRVI | TYRA |
|---|---|---|
| 1 week (5 sessions) | -4.7% | -5.3% |
| 1 month (20 sessions) | 14.9% | 8.1% |
| 3 months (63 sessions) | -26.1% | -23.6% |
| 6 months (126 sessions) | -3.9% | -45.9% |
| Year to date | 9% | -23.8% |
| 1 year (252 sessions) | 15.2% | 29.4% |
Technicals
TRVI has the stronger structure| Metric | TRVI | TYRA |
|---|---|---|
| RSI (14) | 48.5 | 42.8 |
| ADX (14) | 22.7 | 12.1 |
| Price vs 50-day | -2.7% | -7.9% |
| Price vs 200-day | -6% | -31.9% |
| Volatility (1M, annualized) | 76.9% | 51.8% |
Risk
TRVI is the more resilient| Metric | TRVI | TYRA |
|---|---|---|
| Beta | 1.38 | 0.53 |
| Sharpe ratio | 0.52 | 0.65 |
| Sortino ratio | 0.8 | 1 |
| Max drawdown | -39.1% | -53.2% |
| Current drawdown | -30% | -49.4% |
| Annualized volatility | 59.3% | 67.9% |
| Value at risk (95%) | -5.4% | -5.3% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, TRVI or TYRA?
On the Algovestiq AIQ Score, TRVI is the stronger of the two as of Nov 15, 2026, scoring 63 against TYRA's 49. The edge comes from momentum and quality. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is TRVI or TYRA the better buy right now?
TRVI carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Competitive — 3 of 4 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.
Why does the AIQ Score favor TRVI over TYRA?
The composite weights Quality, Value, Momentum and Risk Resilience. TRVI leads Momentum by 25 points; TRVI leads Quality by 7 points; TRVI leads Risk Resilience by 6 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, TRVI or TYRA?
Analyst price targets imply not covered upside for TRVI and +118.5% for TYRA. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, TRVI or TYRA?
Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, TRVI or TYRA?
TYRA on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, TRVI or TYRA?
TRVI on the Momentum factor, by 25 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, TRVI or TYRA?
TRVI is the more resilient of the two, so the other name carries the higher downside risk. TRVI on Risk Resilience, by 6 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is TRVI more profitable than TYRA?
Margin data is not comparable for both names in the current snapshot.
Is TRVI's lead over TYRA getting stronger or weaker?
TRVI lead: Weakening — the AIQ differential moved from 18 to 14 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.
What would change the TRVI vs TYRA verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: TYRA closes the Momentum gap — currently 25 points behind, the largest single contributor to TRVI's edge; TYRA's Death Cross Active resolves — a bearish trend rule currently active against it; TRVI's conflicting signal state resolves bearish — it currently carries 2 bullish and 4 bearish rules at once; the narrowing continues — the lead has already given back 4 points over 30 sessions, and a further 14-point move would eliminate TRVI's advantage entirely.
What do the current signals say about TRVI and TYRA?
TRVI: 2 bullish / 4 bearish / 2 neutral, conflicted. TYRA: 0 bullish / 5 bearish / 2 neutral. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on TRVI is Death Cross Active (bearish, long horizon). On TYRA it is Death Cross Active (bearish, long horizon).
Compare TRVI and TYRA with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.